Attached files

file filename
EX-99.1 - EX-99.1 - Nobilis Health Corp.d240706dex991.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 16, 2016 (December 14, 2016)

 

 

NOBILIS HEALTH CORP.

(Exact name of registrant as specified in its charter)

 

 

 

British Columbia   001-37349   98-1188172

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

11700 Katy Freeway, Suite 300, Houston, Texas   77,079
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (713) 355-8614

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 7.01 REGULATION FD DISCLOSURE.

On December 14, 2016, the Board of Directors of Nobilis Health Corp. (“Nobilis”) approved the delisting of Nobilis’ common shares from the Toronto Stock Exchange (the “TSX”). Nobilis has begun the process of delisting such shares in accordance with the procedures of the TSX. Nobilis’ common shares will continue to be listed on the New York Stock Exchange. On December 15, 2016, Nobilis issued a press release with respect to the delisting of its common shares from the TSX.

The information contained in Item 7.01 to this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing by Nobilis under the Securities Act of 1933, as amended.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

 

Exhibit

Number

  

Exhibit Description

99.1    Press Release dated December 15, 2016


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NOBILIS HEALTH CORP.

/s/ Kenneth Klein

Kenneth Klein

Chief Financial Officer

Date: December 16, 2016